| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2012-11-03 | masitinib | pancreatic cancer | 3 | Skuldtech (France) AB Science (France) | Cancer - Oncology |
| 2012-11-02 | vidofludimus | inflammatory bowel disease |
2 | 4SC (Germany) | Autoimmune diseases - Inflammatory diseases - Digestive diseases |
| 2012-11-02 | GKT137831 | diabetic nephropathy |
1 | Genkyotex (Switzerland) | Metabolic diseases - Renal diseases - Kidney diseases |
| 2012-11-01 | simeprevir (TMC435) and VX-135 | hepatitis C | 2 | Medivir (Sweden) Janssen (J&J - USA) Vertex Pharmaceuticals (USA - MA) | Infectious diseases |
| 2012-11-01 | VX-135 (ALS-2200) and GSK2336805 | hepatitis C |
2 | Vertex Pharmaceuticals (USA - MA) GSK (UK) | Infectious diseases |
| 2012-10-31 | Px-102 | NASH (non-alcoholic steatohepatitis) |
1 | Phenex Pharmaceuticals (Germany) | Metabolic diseases - Liver diseases |
| 2012-10-31 | Ruconest® (Rhucin® in non-European territories - conestat alfa) | acute attacks of angioedema in patients with Hereditary Angioedema (HAE) | Pharming (The Netherlands) | Genetic diseases - Rare diseases | |
| 2012-10-31 | Lemtrada® (alemtuzumab) | patients with relapsing-remitting multiple sclerosis (MS) |
3 | Genzyme (USA - MA), a Sanofi company (France) | Autoimmune diseases - Neurodegenerative diseases |
| 2012-10-30 | OX51 | prevention of procedure-induced pain |
2 | Orexo (Sweden) | CNS diseases |
| 2012-10-26 | imeglimin | type 2 diabetes | 2 | Poxel (France) | Metabolic diseases |
| 2012-10-25 | biosimilar epoetin alfa (Binocrit® in the EU) | anemia associated with chronic kidney disease | 3 | Sandoz (Switzerland) | Kidney diseases - Renal diseases |
| 2012-10-25 | mogamulizumab (KW-0761) | cutaneous T-cell lymphoma | 3 | Kyowa Hakko Kirin Pharma (Japan) | Cancer - Oncology |
| 2012-10-24 | OvaSave® (antigen-specific type 1 regulatory T (Ag-Treg) cell based immunotherapy) | Crohn's disease | 1-2 | TxCell (France) | Autoimmune diseases - Inflammatory diseases - Digestive diseases |
| 2012-10-24 | GLPG0974 | inflammatory bowel disease (IBD) | 1 | Galapagos (Belgium) | Inflammatory diseases |
| 2012-10-23 | reparixin | prevention of graft rejection in pancreatic islet transplantation type 1 diabetes |
3 | Dompé (Italy) | Metabolic diseases |
| 2012-10-22 | candidate quadrivalent influenza vaccine | seasonal influenza |
3 | GSK (UK) | Infectious diseases |
| 2012-10-17 | PLX cells (Placental eXpanded cells) | fibrosis | preclinical data | Pluristem Therapeutics (Israel) | |
| 2012-10-16 | Rencarex® | clear cell renal cell carcinoma (ccRCC) | 3 | Wilex (Germany) | Cancer - Oncology |
| 2012-10-16 | CHF 6001 (inhaled PDE4 (phosphodiesterase 4) inhibitor) | inflammatory respiratory disorders, such as chronic obstructive pulmonary disease (COPD) and asthma |
1 | Chiesi (Italy) | Allergic diseases - Inflammatory diseases - Respiratory diseases |
| 2012-10-12 | Aubagio® (teriflunomide) | relapsing forms of multiple sclerosis | 3 | Genzyme (USA - MA), a Sanofi company (France) | Autoimmune diseases - Neurodegenerative diseases |
